Research ArticleA Platform for Screening Potential Anticholinesterase Fractionsand Components Obtained from Anemarrhena asphodeloidesBge for Treating Alzheimer‚Äôs DiseaseYu Sun,1 Ying Peng,2 Lin-Guang Li,1 Li-Wei Zheng,2 Dong-Ju Lin,2Ling-Zhi Li,1,3 and Shao-Jiang Song1,31 School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China2 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China3 Key Laboratory of Structure-Based, Drug Design & Discovery, Ministry of Education, Shenyang, Liaoning 110016, ChinaCorrespondence should be addressed to Shao-Jiang Song; songsj99@163.comReceived 4 November 2013; Revised 2 March 2014; Accepted 20 March 2014; Published 17 April 2014Academic Editor: Chuthamanee SuthisisangCopyright ¬© 2014 Yu Sun et al. This is an open access article distributed under the Creative Commons Attribution License, whichpermits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Alzheimer‚Äôs disease (AD) is a neurodegenerative disease characterized by progressive memory loss and cognitive impairment.Cholinesterase inhibitors are widely used for the symptomatic treatment of Alzheimer‚Äôs disease to enhance central cholinergictransmission. In this study, a bioactivity-oriented screening platform based on a modified Ellman‚Äôs method and HPLC-QTOF MStechnique was developed to rapidly screen active agents of Anemarrhena asphodeloides Bge. The 60% ethanol fraction from anethyl acetate extract exhibited the most potential anticholinesterase activity. Fifteen steroid saponins were identified by the massspectrum, standards and literature reports. Twenty-five compounds were isolated from the active fraction. The results showedthat compounds with the C6‚ÄìC3‚ÄìC6skeleton probably had both AChE and BuChE inhibitory activities. Xanthone and benzenederivatives exhibited no or little activity. Lignans showed weak BuChE inhibitory activity. The steroidal saponins demonstratedmoderate or weak AChE inhibitory activity.1. IntroductionAlzheimer‚Äôs disease (AD) is a progressive neurodegenerativedisorder of the central nervous system (CNS), characterizedby deposits of aberrant proteins, namely, ùõΩ-amyloid (AùõΩ)and ùúè-protein, loss of synapses, death of cholinergic neurons,and oxidative stress [1, 2]. The etiopathogenesis of AD stillremains unknown, although the neurodegeneration leadsto remarkable reduction of neurotransmitter acetylcholineat the synaptic clefts [3, 4]. An effective strategy to slowdown the progression of deterioration in AD patients is usinganticholinesterase inhibitors.Acetylcholinesterase (AChE) and butyrylcholinesterase(BuChE) constitute the group of cholinesterases. AChEhydrolyses acetylcholine (ACh) and is mainly associated withnerves and muscles, being typically found on the synapses.AChE inhibitors are widely used for the symptomatictreatment of AD to enhance central cholinergic transmission.BuChE hydrolyses butyrylcholine (BuCh) and is synthesizedby the liver, being found in large concentration in serum [5].In healthy brains, AChEhydrolyzes themajority ofAChwhileBuChE plays a secondary role. However, as AD progresses,BuChE can compensate for AChE when the activity of AChEis inhibited by AChE inhibitors. Thus, BuChE hydrolyses thealready depleted levels of ACh in these patients [6]. It hasbeen proposed that individuals with low activity of BuChEcan sustain cognitive functions better than individuals withnormal BuChE activity. Furthermore, BuChE inhibitors havebeen reported to produce a significant increase in brainextracellular AChE without triggering severe peripheral orcentral side effects [7].Anemarrhena asphodeloides Bge, which belongs to thefamily Liliaceae, is widely distributed in China [8]. The rhi-zomes ofAnemarrhena asphodeloides Bge have been reportedHindawi Publishing CorporationEvidence-Based Complementary and Alternative MedicineVolume 2014, Article ID 524650, 11 pageshttp://dx.doi.org/10.1155/2014/5246502 Evidence-Based Complementary and Alternative Medicineto have the cholinesterase inhibitory activity relevant totreatment of AD [9]. In order to find the candidate of adrug treating AD, the activities of fractions and compoundswere assayed. Screening and identification of bioactive con-stituents in traditional Chinese medicines (TCMs) are thekeys of the development of TCMs [10, 11]. However, thecomplexity and variability of TCMs present a challenge tothe identification of their structures. Now more and moreattention has been attracted to bioactivity-based LC-MS/MSidentification technology owing to its high efficiency andhighspecificity [12, 13].In this work, we used a bioactivity-oriented screeningstrategy, which was based on amodified Ellman‚Äôsmethod andhigh performance liquid chromatography quadrupole-time-of-flight mass spectrometer (HPLC-QTOF MS) technique.The 60% ethanol fraction from an ethyl acetate extractshowed the most potential anticholinesterase activity. Fif-teen steroid saponins were identified by the mass spec-trum, standards, and literature reports. Twenty-five com-pounds were isolated from the active fraction. Compoundswith the C6‚ÄìC3‚ÄìC6skeleton probably had both AChE andBuChE inhibitory activities. Xanthone and benzene deriva-tives exhibited no or little activity. Lignans showed weakBuChE inhibitory activity. The steroidal saponins demon-strated moderate or weak AChE inhibitory activity.2. Materials and Methods2.1. Plant Material. The rhizomes of Anemarrhena asphode-loides Bge were purchased from Beijing Tongrentang phar-macy. The plant materials were identified by Professor JincaiLu, Department of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University.2.2. General Instrumental Equipment. HPLC system (Agilent,USA) consisted of a model G1276A pump, model G1367BAutosampler and model G1316A UV detector. The chro-matograph was equipped with a reversed-phase C18 columnof Grace Alltima (250mm √ó 4.6mm, 5 ùúám). The QTOF-MS system (Bruker, Germany) with an ESI source wasperformed. HPLC separations were performed on a Hitachi655-15 series pumping system equipped with a Hitachi L-2490 refractive index detector using a YMC-Park ODS-Acolumn (250√ó 10mm I.D, S-5 ùúám, and 12 nm). NMR spectrawere performed on a Bruker ARX-300, ARX-400, and ARX-600 spectrometer using trimethylchlorosilane as the internalstandard. Column chromatography was performed on a200‚Äì300mesh silica gel (Qingdao Marine Chemical Factory,People‚Äôs Republic of China). Column chromatography wasperformed using YMCODS-A gel (12 nm S-75ùúám, YMCCo.,Ltd., Japan) andD-101macroporous adsorption resin (Shang-hai Hualing Resin Factory, People‚Äôs Republic of China).TLC was performed with precoated silica gel GF254plates(Qingdao Marine Chemical Factory, People‚Äôs Republic ofChina). Microplate reader (Thermofisher Scientific, Finland)was used to test the activities. Acetylthiocholine iodide, S-butyrylthiocholine iodide, AChE, and BuChE were boughtfrom Sigma Company.2.3. Extraction Procedures. Dried rhizomes of Anemarrhenaasphodeloides Bge were powdered into a homogeneous sizeby a disintegrator and then sieved (60 mesh). The materialswere extracted by three different techniques (ultrasonic,heat reflux, and cold soak techniques). Various solventsincluding petroleum ether, dichloromethane, ethyl acetate,acetone, methanol, 95% ethanol, 70% ethanol, 50% ethanol,30% ethanol, and water were used for preparing activefractions. Accurate 5.0 g of the Anemarrhena asphodeloidesBge powders was weighted into ten Erlenmeyer flasks con-taining the mentioned ten solvents of 500mL individuallyand then extracted with ultrasonic-assisted method twice(30min each). After filtering, the filtrates were amalgamatedand evaporated to dryness by rotary evaporator (50‚àòC). Forthe heat reflux, the powders of 5.0 g were soaked in differentsolvents of 50mL each for 30min. Then, the heated refluxextraction experiments were conducted in water bath (90‚àòC)for 2 h. The solutions were filtrated when they were still hot.Extractions were carried out for three times and the filtrateswere evaporated to dryness. Lastly, 5.0 g of the powders wasaccurately weighed and soaked in 500mL solvents overnightand then evaporated the filtrates to dryness.2.4. AChE and BuChE Inhibitory Assay. Cholinesteraseinhibitory activity was evaluated using the modified methodof Ellman. For AChE inhibitory assay, the reaction mixtureconsisted of 50 ùúáL of 100mM PBS, pH 8.0, 25 ùúáL of 15mMacetylthiocholine iodide, and 25 ùúáL of agents (1mg/mL forextracts, 0.1mg/mL for compounds) in a 96-well plate. Themixture was preincubated in 4‚àòC for 10min, and after that,25 ùúáL of AchE (0.226U/mL) and 125 ùúáL of 3mM DTNBwere added. The reactions were kept in 37‚àòC for 20min andthen scanned at 412 nm with a microplate reader. For BuChEinhibitory assay, the same procedures were followed exceptfor the use of substrate and enzyme, and S-butyrylthiocholineiodide and BuchE were used, respectively [14]. All of theexperiments were repeated at least three times.2.5. Structure Characterization and Identification of ActiveFraction. The ethyl acetate extract dealt with by the ultra-sonic method was applied to a D-101macroporous resincolumn and eluted with ethanol and water to give 0%, 20%,40%, 60%, 80%, and 95% ethanol fractions. The constituentsof active fraction were assayed by HPLC-QTOF-MS. HPLCsystem (Agilent, USA) consisted of a model G1276A pump, amodel G1367B Autosampler, and a model G1316A UV detec-tor. The chromatograph was equipped with a reversed-phaseC18 column of Grace Alltima (250mm √ó 4.6 mm, 5ùúám)eluted with a gradient mobile phase. Mobile phases werewater with 0.1% of formic acid (A) and acetonitrile (B). Thegradient used was as follows: 0min, 5% B; 0‚Äì10min, 5% to15%B; 10‚Äì18min, 15% to 20%B; 18‚Äì23min, 20% to 23%B; 23‚Äì30min, 23% to 25% B; 30‚Äì48min, 25% to 30% B; 48‚Äì55min,30% to 50% B; 55‚Äì80min, 50% to 100% B. The injectionvolume of sample was 5 ùúáL. The flow rate was 0.8mLmin‚àí1and the column temperature was ambient temperature. TheQTOF-MS system (Bruker, Germany) with an ESI source wasperformed in positive mode.The parameters of ESI-MS wereEvidence-Based Complementary and Alternative Medicine 3 The extract of Anemarrhena asphodeloides BgeD-101 macroporous resin columnA B C D E FD.1 D.2 D.3 D.4 D.5Reversed-phase C18 silica gel Reversed-phase C18 silica gelD.2.1 D.2.2 D.2.3 D.4.1 D.4.2 D.4.3 D.4.4HPLCSilica gelSephadex LH-20Pre-HPLCSephadex LH-20Pre-HPLC Pre-HPLCSilica gel16‚Äì25Components Components Components Components13‚Äì15 1‚Äì7 8‚Äì12Figure 1: The isolation procedure of Anemarrhena asphodeloides Bge.set as follows: the capillary voltage (+3800V), the nebulizergas pressure (1.2 bar), the dry gas flow rate (8.0 Lmin‚àí1), andtemperature (180‚àòC). MS conditions were corrected by directinfusion of sodium formic acid solution (1mML‚àí1) deliveredby a syringe pump at a flow rate of 3 ùúáLmin‚àí1. The data wereanalyzed by Bruker Daltonics Data Analysis 3.4 software.2.6. Isolation and Purification of Compounds from Ane-marrhena asphodeloides Bge. The extract of Anemarrhenaasphodeloides Bge (400.0 g) was subjected to CC (macrop-orous adsorption resin D-101; gradient EtOH/H2O 0 : 100 to95 : 5) to afford six fractions (Frs. A‚ÄìF). Fr. D (62.0 g) wassubjected to CC (silica gel; CH2Cl2/MeOH 100 : 0 to 0 : 100)and afforded five fractions (Frs. D.1‚ÄìD.5). Fr. D.2 (5.2 g) wassubjected to CC (reversed-phase C18silica gel; MeOH/H2O30 : 70 to 100 : 0) to afford three fractions (Frs. D.2.1‚ÄìD.2.3).Fr. D.2.2 (0.7 g) was further purified by RP-HPLC withMeOH/H2O as mobile phase (85 : 15) to afford compounds13 to 15. Fr. D.3 (2.3 g) was subjected to CC (Sephadex LH-20; MeOH) and then purified by RP-HPLCwithMeOH/H2Oas mobile phase (80 : 10) to afford compounds 1 to 7. Fr. D.4(21.0 g) was subjected to CC (reversed-phase C18silica gel;MeOH/H2O 30 : 70 to 100 : 0) and afforded four fractions. Fr.D.4.2 (3.3 g) was subjected to CC (Sephadex LH-20; MeOH)and then purified by RP-HPLC with MeOH/H2O as mobilephase (50 : 50) to afford compounds 8 to 12. Fr. D.4.4 (9.7 g)was subjected to CC (silica gel; CH2Cl2/MeOH 30 : 70 to100 : 0) and then purified by RP-HPLC with MeOH/H2O asmobile phase (70 : 30) to afford compounds 16 to 25. Theisolation procedure of Anemarrhena asphodeloides Bge isshown in Figure 1.2.7. Statistical Analysis. Data were expressed as means ¬±S8EM and analyzed statistically by one-way ANOVA, fol-lowed by post hoc (LSD) test. The results were consideredstatistically significant at ùëÉ value < 0.05.3. Results3.1. The Activities of the Extracts. Screening the extractsof Anemarrhena asphodeloides Bge dealing with three dif-ferent techniques and ten kinds of solvents showed thatall the extracts demonstrated no AchE inhibitory activitybut exhibited BuChE inhibitory activity. The extract dealingwith dichloromethane, ethyl acetate, and acetone had muchmore inhibition ratio than the others. The ultrasonic methodand the cold soak method were better than the heat refluxmethod. It was found that Anemarrhena asphodeloides Bgeextracted with ethyl acetate by the ultrasonic technique hadthe most potential anticholinesterase activity. The resultson the effects of the tested extracts on AChE and BuChEinhibitory activities were summarized in Table 1.3.2. Screening the Active Fraction. The extract dealing withethyl acetate by the ultrasonic method was applied to a D-101macroporous resin column and elutedwith ethanol andwaterto give 0%, 20%, 40%, 60%, 80%, and 95% ethanol fractions.Then they were tested on AChE and BuChE inhibitoryactivities. It indicated that the extract was partitioned into sixfractions and active compounds were concentrated into 60%ethanol fraction. The results were summarized in Figure 2.Donepezil was used as positive drug with the inhibition ratioof 98.2% and 79.8%.4 Evidence-Based Complementary and Alternative MedicineTable 1: The effects of the tested extracts on AChE and BuChE inhibitory activities.Solvents AChE inhibition (%) BuChE inhibition (%)Ultrasonic method Heat reflux method Cold soak method Ultrasonic method Heat reflux method Cold soak methodPetroleum ether ‚Äî ‚Äî ‚Äî ‚Äî ‚Äî 1.6 ¬± 0.1Dichloromethane ‚Äî ‚Äî ‚Äî 41.5 ¬± 0.5 15.7 ¬± 0.7 41.2 ¬± 0.6Ethyl acetate ‚Äî ‚Äî ‚Äî 44.1 ¬± 0.5 27.7 ¬± 0.4 40.8 ¬± 0.8Acetone ‚Äî ‚Äî ‚Äî 38.8 ¬± 0.3 22.2 ¬± 0.3 37.9 ¬± 0.7Methanol ‚Äî ‚Äî ‚Äî 12.3 ¬± 0.4 5.4 ¬± 0.2 7.1 ¬± 0.395% ethanol ‚Äî ‚Äî ‚Äî 4.9 ¬± 0.2 2.8 ¬± 0.1 3.9 ¬± 0.370% ethanol ‚Äî ‚Äî ‚Äî 1.8 ¬± 0.1 ‚Äî 1.6 ¬± 0.250% ethanol ‚Äî ‚Äî ‚Äî 2.8 ¬± 0.1 ‚Äî 0.5 ¬± 0.130% ethanol ‚Äî ‚Äî ‚Äî 2.4 ¬± 0.1 ‚Äî 1.8 ¬± 0.2Water ‚Äî ‚Äî ‚Äî ‚Äî ‚Äî ‚ÄîAChE inhibition ratio of donepezil: 98.0 ¬± 0.5; BuChE inhibition ratio of donepezil: 80.2 ¬± 0.6.9080706050403020100Inhibition ratio (%)Water 20% ethanol40% ethanol60% ethanol80% ethanol95% ethanol0.47.755.113.181.332.614.7AChE inhibitionBuChE inhibitionFigure 2: The effects of ethanol and water fractions on AChE andBuChE inhibitory activities.3.3. Structure Characterization and Identification of the ActiveFraction. The 20%, 40%, 60%, 80%, and 95% ethanol frac-tions were analyzed by HPLC-QTOF-MS technique. Thewater fraction was not tested for its inactivity. The total ionchromatograms of the five fractions were shown in Figure 3.As summarized in Table 2, a total of fifteen saponins fromthe 60% ethanol fraction were identified and tentativelycharacterized.To obtain the information about precursor ions andcharacteristic fragment ions of the compounds, six authenticstandardswere injected into the LC-MS system.The fragmen-tation patterns for these authentic standards were discussedin detail below. MS spectra of the authentic standards wereshown in Figure 4.Timosaponin BII produced a precursor ion [M + Na]+at ùëö/ùëß 943.4872 (C45H76O19Na). As the C22 position wasan active site, it readily eliminated the 22-hydroxyl residueto produce the thermal degradation ion [M + H ‚Äì H2O]+at ùëö/ùëß 903.4982 (C45H75O18), which could generate an ion20% ethanol fraction40% ethanol fraction60% ethanol fraction80% ethanol fraction95% ethanol fraction2.01.00.02.01.00.064200.80.40.03210IntensityIntensityIntensityIntensityIntensity706050403020100706050403020100706050403020100706050403020100706050403020100Time (min)Time (min)Time (min)Time (min)Time (min)√ó106√ó106√ó106√ó105√ó105Figure 3: The total ion chromatograms of the five fractions.at ùëö/ùëß 741.4468 [M + H ‚Äì H2O ‚Äì 162]+ by further neutralloss of a glucose moiety from the C26 position. At the sametime, the product ions at 579.3934 [M + H ‚Äì H2O ‚Äì 2√ó162]+and 417.3251 [M + H ‚Äì H2O ‚Äì 3 √ó 162]+, which correspondedto skeleton residues by successive losses of terminal hexose,could also be clearly observed. Furthermore, the fragmentEvidence-Based Complementary and Alternative Medicine 5Table2:HPLC/Q-TOFMSanalysisforaccuratemassmeasurementsofconstituentsin60%ethanolfraction.NumberùëáùëÖ(min)FormulaSelectedionTheoreticalmass(ùëö/ùëß)Experimentalmass(ùëö/ùëß)Error(ppm)Fragmentionsinpositive(+)ionmodeIdentification129.8C 45H76O20[M+Na]+959.4822959.4833‚àí1.1919,757,595,433,415,271,253TimosaponinN231.7C 45H74O19[M+Na]+941.4717941.4726‚àí1.0901,739,577,415,273,255TimosaponinM337.6C 45H76O19[M+Na]+943.4873943.4886‚àí1.4903,741,579,417,273,255TimosaponinBII438.5C 45H76O19[M+Na]+943.4873943.4882‚àí1.0903,741,579,417,273,25525R-TimosaponinBII539.2C 45H76O19[M+Na]+943.4873943.48710.2903,741,579,417,273,25525S-Officinalisnin-I654.9C 45H74O18[M+Na]+925.4767925.4788‚àí2.3741,579,417,273,255TimosaponinBIII756.7C 39H64O14[M+Na]+779.4188779.4202‚àí1.8739,595,433,415,273,255TimosaponinG857.6C 39H66O14[M+Na]+781.4345781.4367‚àí2.8741,579,417,399,271,253AnemarrhenasaponinI958.0C 39H64O14[M+Na]+779.4188779.4189‚àí0.1739,577,415,273,255IsomeroftimosaponinG1058.6C 39H64O14[M+Na]+779.4188779.41840.5739,595,433,415,271,25325(27)-ene-AnemarrhenasaponinI1160.4C 39H64O14[M+Na]+779.4188779.41870.1757,595,433,415,271,253TimosaponinA21262.2C 39H64O13[M+Na]+763.4239763.42370.3579,417,273,255TimosaponinAIV1363.9C 39H64O13[M+Na]+763.4239763.4241‚àí0.3579,417,273,255TimosaponinAIII1464.4C 39H64O13[M+Na]+763.4239763.42212.4579,417,273,25525R-TimosaponinAIII1575.8C 33H54O8[M+Na]+601.3711601.37031.3417,273,255TimosaponinAI6 Evidence-Based Complementary and Alternative Medicine579.3934 741.4468903.4982943.487200246Intensity100 200 300 400 500 600 800700 900(m/z)(m/z)(m/z)417.3389579.3969741.4406763.42520.00.20.40.60.8273.2230273.2220 417.3363579.3915741.44360.00.20.40.60.81.0763.4245255.2107417.3410 579.3917741.4505781.43500246271.1636253.1493417.3251273.2139255.2030579.3948 741.4482903.4941100020003000Intensity100 200 300 400 500 600 700100 200 300 400 500 600 700(m/z)100 200 300 400 500 600 700(m/z)100 200 300 400 500 600 700(m/z)100 200 300 400 500 600 700800 900925.4793417.3240273.2143          255.2040433.3368595.3933739.4281779.41940.00.20.40.60.81.0IntensityIntensityIntensityIntensity255.2000273.2127Timosaponin BIITimosaponin BIIITimosaponin GAnemarrhena saponin I Timosaponin AIVTimosaponin AIII255.2105757.4351415.3244√ó104√ó104√ó105√ó105√ó105Figure 4: MS spectra of the authentic standards.ion at ùëö/ùëß 273.2139 [417.3251 ‚Äì C8H16O2]+ was attributed toa skeleton residue by the cleavage of the C20‚ÄìC22 and C17‚ÄìC20 bonds due to the presence of a 16,22-epoxy residue and a22,26-epoxy residue, and then the ion continued to lose H2Oto yield an ion at ùëö/ùëß 255.2030 [273.2139 ‚Äì H2O]+. Majorfragmentations proposed for timosaponin BII were presentedin Figure 5.Timosaponin BIII gave an [M + H]+ ion atùëö/ùëß 903.4941and an [M + Na]+ ion at ùëö/ùëß 925.4793, corresponding toan elemental composition C45H74O18. Its successive losses ofone galactosyl and two glucosyls from the protonated ion ledto the product ions atùëö/ùëß 741.4482 [M +H ‚Äì 162]+, 579.3948[M + H ‚Äì 2 √ó 162]+, and 417.3240 [M + H ‚Äì 3 √ó 162]+. Inaddition, the fragment ions found atùëö/ùëß 273.2143 [417.3240 ‚ÄìC8H16O2]+ and 255.2040 [273.2143 ‚Äì H2O]+ were originatedfrom the consecutive elimination of the E-ring and H2O.Timosaponin G produced a precursor ion [M + Na]+ atùëö/ùëß 779.4194. It showed a series of fragment ions at ùëö/ùëß595.3933 [M + H ‚Äì 162]+, 433.3368 [M + H ‚Äì 2 √ó 162]+, and415.3244 [M+H‚ÄìH2O‚Äì 2√ó 162]+, which could be attributedto losses of one glucosyl, one galactosyl, and H2O from [M +H]+ (ùëö/ùëß 757.4351). The fragment ions 273.2127 [415.3244 ‚ÄìC8H14O2]+ and 255.2000 [273.2127 ‚Äì H2O]+ were producedby the consecutive elimination of the E-ring and H2O.Anemarrhena saponin I yielded the sodic adduct ion [M+Na]+ atùëö/ùëß 781.4350, corresponding to itsmolecular formulaEvidence-Based Complementary and Alternative Medicine 7HOHOHOOH OHOHONa+O-Glc O-GlcH H H HHHHGlc Gal-O Glc Gal-O Gal-O‚àíH2O‚àíH2O[M + Na]+ 943.4872 [M + H]+ 903.4982OH+ OH+OH+OH+‚àíGlc‚àíGlc[M + H]+ 741.4468 [M + H]+ 579.3934‚àíGal[M + H]+ 417.3251E cleavage[M + H]+ 273.2319++[M + H]+ 255.20302 2 Glc Gal-O2Figure 5: The proposed ESI-MS/MS fragmentation pathway of timosaponin BII.Glc Gal-OGlc Man-O Gal-OHOHOHOOHOHOH OHOHHO HO HO HOHOHOHOHOO-GlcO-GlcO-Glc O-Glc O-Glc O-GlcH H H H HHHHHH HHHHHOOOOOOOOOO OOOOO OOO O O OTimosaponin MTimosaponin N Timosaponin BII 25R-Timosaponin BIITimosaponin BIII Timosaponin GTimosaponin AI25R-Timosaponin AIII25(27)-ene-anemarrhena saponin IAnemarrhena saponin I Isomer of  timosaponin G25S-OÔ¨ÉcinalisninTimosaponin A2 Timosaponin AIV Timosaponin AIII2Glc Gal-O2 Glc Gal-O2 Glc Gal-O2 Glc Gal-O2Glc Glc-O2Glc Gal-O2Glc Gal-O2Glc Gal-O2Glc Gal-O2 Glc Gal-O2 Glc Gal-O2Glc Gal-O22Figure 6: The proposed structures of the fifteen compounds identified by Q-TOF-MS.as C39H66O14. The main fragment ions at ùëö/ùëß 741.4505 [M+ H ‚Äì H2O]+, 579.3817 [M + H ‚Äì H2O ‚Äì 162]+, 417.3410[M + H ‚Äì H2O ‚Äì 2 √ó 162]+, and 399.2059 [M + H ‚Äì 2 √óH2O ‚Äì 2 √ó 162]+ were produced directly from the parention, which could be attributed to losses of H2O, one glucosyl,one galactosyl, and H2O. Similarly, the fragment ions at ùëö/ùëß271.1636 [417.3410 ‚Äì C8H18O2]+ and 253.1493 [271.1636 ‚ÄìH2O]+ were also daughter ions produced from the parentions by consecutive elimination of the E-ring and H2O.Timosaponin AIII displaying a series of fragment ionsat ùëö/ùëß 579.3969 [M + H ‚Äì 162]+, 417.3389 [M + H ‚Äì 2√ó 162]+, and 399.3294 [M + H ‚Äì H2O ‚Äì 2 √ó 162]+ couldbe attributed to losses of one glucosyl, one galactosyl, andH2O from 741.4406 [M + H]+. The characteristic fragmentions at ùëö/ùëß 273.2230 [417.3389 ‚Äì C8H16O2]+ and 255.2105[273.2230 ‚Äì H2O]+ resulted from consecutive losses of E-ringand H2O. Timosaponin AIV had the same formula and thesimilar fragmentation behavior as timosaponin AIII.Based on the exact mass, authentic standards, fragmentions, retention time, and structures in the literature [15‚Äì24],the structures of the fifteen compounds (Figure 6) from the60% ethanol fraction (Figure 7) were deduced as follows.Peak 1 presented [M + Na]+ ion with mass accuracy atùëö/ùëß 959.4833. The molecular mass was 16Da heavier thanthat of timosaponin BII. It produced fragment ions at ùëö/ùëß919 [M + H ‚Äì H2O]+, 757 [M + H ‚Äì H2O ‚Äì 162]+, 595 [M+ H ‚Äì H2O ‚Äì 2 √ó 162]+, 433 [M + H ‚Äì H2O ‚Äì 3 √ó 162]+, and415 [M + H ‚Äì 2 √ó H2O ‚Äì 3 √ó 162]+, which were attributed8 Evidence-Based Complementary and Alternative Medicine0 10 20 30 40 50 60 70Time (min)0.00.20.40.60.81.01 32 48 14 5 10 9 7 6 13 11 15 12 √ó105IntensityFigure 7: The peak numbers of 60% ethanol fraction.to the sequential losses of H2O, one galactosyl, two glucosyls,and H2O. Moreover, it was noteworthy that the fragmentions at ùëö/ùëß 271 [415 ‚Äì C8H16O2]+ and 253 [271 ‚Äì H2O]+originating from the consecutive elimination of the E-ringand H2O were observed in the MS/MS spectrum. It wassuggested that one more hydroxyl group substituent was atC2 position. Based on the fragment ions and retention time,it was tentatively identified as timosaponin N.Peak 2, the major fragment ions at ùëö/ùëß 901 [M + H ‚ÄìH2O]+, 739 [M + H ‚Äì H2O ‚Äì 162]+, 577 [M + H ‚Äì H2O ‚Äì 2 √ó162]+, 415 [M + H ‚Äì H2O ‚Äì 3 √ó 162]+, 273 [415 ‚Äì C8H14O2]+,and 255 [273 ‚Äì H2O]+, could be attributed to losses of H2O,three hexosyl residues, one formula C8H14O2,and H2O fromthe ion [M+Na]+ (ùëö/ùëß 941.4726).Therewas one double bondat the C25 and C27 positions [8]. Peak 2 was identified astimosaponin M.Peak 3 was definitely identified as timosaponin BIIin comparison with an authentic standard. The precursorion [M + Na]+ at ùëö/ùëß 943.4886 was the base peak inESI experiments. Peaks 4 and 5 showed the same formulaand similar fragment ions as peak 3. Based on the chro-matography behavior of steroidal saponin on a C18column,peak 4 was tentatively identified as the C25R stereoisomerof timosaponin BII. While peak 5 was identified as 25S-officinalisnin-I or its isomer [8].Peak 6, peak 7, and peak 8 were identified as timosaponinBIII, timosaponin G, andAnemarrhena saponin I in compar-ison with authentic standards.Peak 9 showed [M + Na]+ (ùëö/ùëß 779.4189) and [M +H ‚Äì H2O]+ (ùëö/ùëß 739.4244) ions. The fragment ions at ùëö/ùëß577 [M + H ‚Äì H2O ‚Äì 162]+, 415 [M + H ‚Äì H2O ‚Äì 2 √ó162]+, 273 [415 ‚Äì C8H14O2]+, and 255 [273 ‚Äì H2O]+ wereproduced, corresponding to the neutral losses of one glucosyl,one galactosyl, E-ring, and H2O. It was tentatively identifiedas isomer of timosaponin G.Peak 10 presented [M + Na]+ ion with mass accuracy atùëö/ùëß 779.4184. In addition to the dehydrated product ion atùëö/ùëß 739 [M + H ‚àí H2O]+, a series of characteristic productions at ùëö/ùëß 595 [M + H ‚Äì 162]+, 433 [M + H ‚Äì 2 √ó 162]+, 415[M + H ‚Äì H2O ‚Äì 2 √ó 162]+, 271 [415 ‚Äì C8H16O2]+, and 253[271 ‚Äì H2O]+ were also observed. It was tentatively identifiedas 25(27)-ene-Anemarrhena saponin I.Peak 11was calculated asC39H64O14based on the accuratemass measurement [M + Na]+ (ùëö/ùëß 779.4187). The ions atùëö/ùëß 757 [M+H]+, 595 [M+H‚Äì 162]+, 433 [M+H‚Äì2√ó 162]+,415 [M +H ‚ÄìH2O ‚Äì 2 √ó 162]+, 271 [415 ‚Äì C8H16O2]+, and 253[271 ‚Äì H2O]+ indicated one hydroxyl group substituent of theaglycone. It was tentatively identified as timosaponin A2.Peaks 12 and 13 were identified as timosaponin AIV andtimosaponin AIII by authentic standards. Peak 14 yielded thesodic adduct ion [M + Na]+ at ùëö/ùëß 763.4237. It displayeda series of fragment ions at ùëö/ùëß 579 [M + H ‚Äì 162]+,417 [M + H ‚Äì 2 √ó 162]+, 273 [417 ‚Äì C8H16O2]+, and 255[273 ‚Äì H2O]+. The retention time of steroidal saponinswith the 25R configuration was longer than those with the25S configuration. Peak 14 was tentatively identified as 25R-timosaponin AIII.Peak 15 showed the [M + H]+ ion at ùëö/ùëß 579.3892(C33H55O8), 162 Da less than that of timosaponin AIII. Theproduct ions such as ùëö/ùëß 417 [M + H ‚Äì 162]+, 399 [M + H ‚ÄìH2O ‚Äì 162]+, 273 [417 ‚Äì C8H16O2]+, and 255 [273 ‚Äì H2O]+could be found in their MS/MS spectrum. From this, peak 15was identified as timosaponin A-I.3.4. Isolation and Purification of Compounds from Ane-marrhena asphodeloides Bge. Twenty-five compounds wereobtained after repeated isolation and purification. On thebasis of spectroscopic analysis (MS, 1H NMR, 13C NMR,DEPT135, HSQC, HMBC, and NOESY spectra) and in com-parison with the previously reported spectral data [25‚Äì34],the structures of these compounds were shown in Figure 8.All the isolates were subjected to the cholinesterase inhibitoryactivity assay (Table 3).4. DiscussionThe anticholinesterase activity of the agents was tested inthe presence of a known concentration. It was one of theapproaches to study the effect of treating Alzheimer‚Äôs disease.The anticholinesterase inhibition ratio of the agents wasexpressed as percentage inhibition ratio based on the opticaldensity. The conditions of AChE and BuChE inhibitoryassay were confirmed by a series of literature reports andexperiments.To determine which fraction has anticholinesterase activ-ity, the rhizome of Anemarrhena asphodeloides was fraction-ated further by a series of extractions with different solventsand techniques. The findings revealed that more bioactivecomponents would be extracted by dichloromethane, ethylacetate, and acetone.The extracts dealt with by the ultrasonicand cold soak method had higher inhibition ratio than theextracts dealt with by the heat reflux method. It is proposedthat the molecular structures of the active constituents maybe destroyed at a high temperature.Evidence-Based Complementary and Alternative Medicine 9HOHOHOHO HOHOHOHOHOHOHOHO HOHOHOOHOHOHOHOH OH OHOHOHOHOHOHOHOHOHOHOHO OOOOOOOOOOOOOOOOOO OOOO O OOOOOOHOHO-GlcO-GlcO-GlcO-GlcO-GlcO-GlcHHHHHH H H HHHHHGlcGlcGlcGlcGlcXylGlc 422 3Gal-OH3COH3COH3COH3COH3COH3COGlc Man-O2Glc Gal-ORha Glc2Glc Gal-O2Glc Gal-O 2Glc Gal-O 2Glc Gal-O2Glc Gal-O2Glc Gal-O 2Glc Gal-OOCH3OCH3OCH3OCH3OCH3 OCH3OCH3OCH31‚Äì6CH2OH1 2 3 4 56 7 8 9 1011 12 13 14 1516 17 18 19 2021 22 23 24 25Figure 8: The structures of the isolated compounds.The effect of ethyl acetate extract extracted by the ultra-sonic method on inhibiting activity of cholinesterase wasbetter than those dealt with by other solvents and methods.The ethyl acetate crude extract ofAnemarrhena asphodeloidesmay also contain many compounds with differing polarities,so it was fractionated further by a D-101 macroporousresin column. The bioactive compounds of the 60% ethanolfraction were analyzed by HPLC-QTOF-MS system.The type of compounds in the 60% ethanol fraction couldbe deduced by the MS data. If the ions [M + Na]+ and [M +H ‚àí H2O]+ were detected and the [M+H]+ ion was notobserved, the saponin would be a furostanol saponin withthe C22 hydroxyl group. If the ions at ùëö/ùëß 417, 255, and 273were detected, there should be no substituent attached to thesarsasaponin. If the ions at ùëö/ùëß 433 and 415 were observed,there should be one more hydroxyl group substituent on theaglycone.The retention time of saponins would be affected bythe number, classes, and connection orders of sugar moietiesand the number and position of hydroxyl group substituentat the aglycone. What is more, the retention time of steroidalsaponins with the 25R configuration was longer than thosewith the 25S configuration on a C18 column.Twenty-five compounds were isolated from the activefraction. The structure-activity relationships were discussedbased on the results of cholinesterase inhibitory activity. Itshowed that the compounds with the C6‚ÄìC3‚ÄìC6skeletonprobably had both AChE and BuChE inhibitory activities.Compound 3 showed potential BuChE inhibitory activititywith the inhibition ratio of 75.8%. Xanthone and benzenederivatives exhibited no or little activity. Lignans showedweak BuChE inhibitory activity. The steroidal saponins hadmoderate or weak AChE inhibitory activity. It was supposedthat addingOHgroups to the steroidal saponinsmay increasethe effect a little. Although some of the individual compoundsexhibited potential in vitro activity, they were less effectivethan the 60% ethanol fraction and this might be due to asynergistic action among the active components ormaybe themost active constituents have not been isolated by us.Steroid saponins were considered as potentially drugpreventing and treating neurodegenerative diseases, such asAlzheimer‚Äôs disease. However, we found that compoundswith the C6‚ÄìC3‚ÄìC6skeleton probably had both AChE andBuChE inhibitory activities, especially compound 3. Theactivity in vivo needs to be tested in the future.5. ConclusionAChE and BuChE inhibitory activities of Anemarrhenaasphodeloides Bge extracted with three different techniques10 Evidence-Based Complementary and Alternative MedicineTable 3: The effects of the twenty-five compounds on AChE andBuChE inhibitory activities.Compounds AChE inhibition (%) BuChE inhibition (%)1 17.9 ¬± 0.3 37.6 ¬± 0.62 15.2 ¬± 0.2 28.1 ¬± 0.43 12.5 ¬± 0.4 75.8 ¬± 0.74 ‚Äî ‚Äî5 14.1 ¬± 0.3 35.3 ¬± 0.56 17.9 ¬± 0.2 36.0 ¬± 0.47 14.2 ¬± 0.5 0.6 ¬± 0.18 ‚Äî ‚Äî9 ‚Äî ‚Äî10 0.9 ¬± 0.1 0.1 ¬± 0.111 7.9 ¬± 0.3 4.0 ¬± 0.212 1.7 ¬± 0.2 15.1 ¬± 0.313 18.5 ¬± 0.4 0.5 ¬± 0.114 27.2 ¬± 0.2 4.2 ¬± 0.215 21.6 ¬± 0.4 ‚Äî16 1.1 ¬± 0.1 ‚Äî17 13.2 ¬± 0.3 ‚Äî18 15.9 ¬± 0.4 ‚Äî19 23.5 ¬± 0.4 12.3 ¬± 0.620 18.4 ¬± 0.4 ‚Äî21 19.2 ¬± 0.3 ‚Äî22 17.3 ¬± 0.3 ‚Äî23 20.3 ¬± 0.5 7.3 ¬± 0.224 21.1 ¬± 0.6 ‚Äî25 22.4 ¬± 0.2 2.8 ¬± 0.2Donepezil 98.2 ¬± 0.8 79.8 ¬± 0.7and ten kinds of solvents were studied. Anemarrhena aspho-deloides Bge extracted with ethyl acetate by the ultrasonictechnique had the most potential anticholinesterase activity.The extract was partitioned into six fractions after applying toa D-101 macroporous resin column, and active compoundswere concentrated into 60% ethanol fraction. Fifteen mainpeaks of this fraction were identified and tentatively charac-terized based on the HPLC-QTOF-MS technique, standards,and literature reports. Twenty-five compounds were obtainedfrom 60% ethanol fraction after repeated isolation and purifi-cation. The structure-activity relationships were discussedbased on the results of cholinesterase inhibitory activity.Conflict of InterestsThe authors declare that there is no conflict of interestsregarding the publication of this paper.AcknowledgmentsThe authors are grateful to financial supports from Nat-ural Science Foundation of China (81373925), ‚ÄúLiaon-ing Bai Qian Wan Talents Program‚Äù (2011921044), SocialDevelopment Project of Liaoning Science and TechnologyCommittee (2011404012-3), Liaoning Province DoctoralScientific Research Start-up Funds (20111139), Project ofShenyang Science and Technology Bureau (F12-161-9-00),Program for Innovative Research Team of the Ministry ofEducation, and Program for Liaoning Innovative ResearchTeam in University.References[1] M. Goedert and M. G. Spillantini, ‚ÄúA century of Alzheimer‚Äôsdisease,‚Äù Science, vol. 314, no. 5800, pp. 777‚Äì781, 2006.[2] J. S. da Costa, J. P. B. Lopes, D. Russowsky et al., ‚ÄúSynthesis oftacrine-lophine hybrids via one-pot four component reactionand biological evaluation as acetyl- and butyrylcholinesteraseinhibitors,‚ÄùEuropean Journal ofMedicinal Chemistry, vol. 62, pp.556‚Äì563, 2013.[3] H. Q. Lin, M. T. Ho, L. S. Lau, K. K. Wong, P. C. Shaw, andD. C. C.Wan, ‚ÄúAnti-acetylcholinesterase activities of traditionalChinese medicine for treating Alzheimer‚Äôs disease,‚Äù Chemico-Biological Interactions, vol. 175, no. 1‚Äì3, pp. 352‚Äì354, 2008.[4] E. Perry, J. Court, R. Goodchild et al., ‚ÄúClinical neurochemistry:developments in dementia research based on brain bank mate-rial,‚Äù Journal of Neural Transmission, vol. 105, no. 8-9, pp. 915‚Äì933, 1998.[5] R. T. Delfino, T. S. Ribeiro, and J. D. figueroa-Villar, ‚ÄúOrgano-phosphorus compounds as chemical warfare agents: a review,‚ÄùJournal of the Brazilian Chemical Society, vol. 20, no. 3, pp. 407‚Äì428, 2009.[6] E. K. Perry, R. H. Perry, G. Blessed, and B. E. Tomlin-son, ‚ÄúChanges in brain cholinesterases in senile dementia ofAlzheimer type,‚ÄùNeuropathology andAppliedNeurobiology, vol.4, no. 4, pp. 273‚Äì277, 1978.[7] N. Wszelaki, A. Kuciun, and A. Kiss, ‚ÄúScreening of tradi-tional European herbal medicines for acetylcholinesterase andbutyrylcholinesterase inhibitory activity,‚Äù Acta Pharmaceutica,vol. 60, no. 1, pp. 119‚Äì128, 2010.[8] Y. Zhao, L. P. Kang, H. S. Yu et al., ‚ÄúStructure characterizationand identification of steroidal saponins from the rhizomesof Anemarrhena asphodeloides by ultra performance liquid-chromatography and hybrid quadrupole time-of-flight massspectrometry,‚Äù International Journal of Mass Spectrometry, vol.7, no. 17, pp. 341‚Äì342, 2013.[9] B. Lee, K. Jung, and D.-H. Kim, ‚ÄúTimosaponin AIII, a saponinisolated from Anemarrhena asphodeloides, ameliorates learningand memory deficits in mice,‚Äù Pharmacology Biochemistry andBehavior, vol. 93, no. 2, pp. 121‚Äì127, 2009.[10] Z. X. Peng, Y. Wang, X. Gu, Y. Y. Wen, and C. Yan, ‚ÄúA platformfor fast screening potential anti-breast cancer compounds intraditional Chinese medicines,‚Äù Biomedical Chromatography,vol. 27, no. 12, pp. 1759‚Äì1766, 2013.[11] X. Zhang, L.-W. Qi, L. Yi, P. Li, X.-D. Wen, and Q.-T. Yu,‚ÄúScreening and identification of potential bioactive componentsin a combined prescription of Danggui Buxue decoction usingcell extraction coupled with high performance liquid chro-matography,‚Äù Biomedical Chromatography, vol. 22, no. 2, pp.157‚Äì163, 2008.[12] Y. Hou, X. Cao, L. Dong et al., ‚ÄúBioactivity-based liquidchromatography-coupled electrospray ionization tandem iontrap/time of flight mass spectrometry for ùõΩ2AR agonist iden-tification in alkaloidal extract of Alstonia scholaris,‚Äù Journal ofChromatography A, vol. 1227, pp. 203‚Äì209, 2012.Evidence-Based Complementary and Alternative Medicine 11[13] Z.-H. Su, G.-A. Zou, A. Preiss, H.-W. Zhang, and Z.-M.Zou, ‚ÄúOnline identification of the antioxidant constituentsof traditional Chinese medicine formula Chaihu-Shu-Gan-San by LC-LTQ-Orbitrap mass spectrometry and microplatespectrophotometer,‚Äù Journal of Pharmaceutical and BiomedicalAnalysis, vol. 53, no. 3, pp. 454‚Äì461, 2010.[14] G. L. Ellman, K. D. Courtney, V. Andres Jr., and R. M.Featherstone, ‚ÄúA new and rapid colorimetric determination ofacetylcholinesterase activity,‚Äù Biochemical Pharmacology, vol. 7,no. 2, pp. 88‚Äì95, 1961.[15] J. Zhang, B. P. Ma, L. P. Kang et al., ‚ÄúFurostanol saponins fromthe fresh rhizomes of Polygonatum kingianum,‚Äù Chemical andPharmaceutical Bulletin, vol. 54, no. 7, pp. 931‚Äì935, 2006.[16] J. Zhu, X. Guo, S. Fu, X. Zhang, and X. Liang, ‚ÄúCharacteri-zation of steroidal saponins in crude extracts from Dioscoreazingiberensis C. H. Wright by ultra-performance liquid chro-matography/electrospray ionization quadrupole time-of-flighttandem mass spectrometry,‚Äù Journal of Pharmaceutical andBiomedical Analysis, vol. 53, no. 3, pp. 462‚Äì474, 2010.[17] L. P. Kang, J. Zhang, Y. Cong et al., ‚ÄúSteroidal glycosides from therhizomes of Anemarrhena asphodeloides and their antiplateletaggregation activity,‚Äù Planta Medica, vol. 78, no. 6, pp. 611‚Äì616,2012.[18] L. P. Kang, K. Yu, Y. Zhao et al., ‚ÄúCharacterization of steroidalglycosides from the extract of Paris Polyphylla var. Yunnanensisby UPLC/Q-TOFMSE,‚Äù Journal of Pharmaceutical and Biomed-ical Analysis, vol. 62, no. 6, pp. 235‚Äì249, 2012.[19] L. P. Kang, Y. Zhao, X. Pang et al., ‚ÄúCharacterization andidentification of steroidal saponins from the seeds of Trigonellafoenum-graecum by ultra high-performance liquid chromatog-raphy and hybrid time-of-flight mass spectrometry,‚Äù Journal ofPharmaceutical and Biomedical Analysis, vol. 74, no. 23, pp. 257‚Äì267, 2013.[20] R. Li, Y. Zhou, Z. Wu, and L. Ding, ‚ÄúESI-QqTOF-MS/MSand APCI-IT-MS/MS analysis of steroid saponins from therhizomes ofDioscorea panthaica,‚Äù Journal ofMass Spectrometry,vol. 41, no. 1, pp. 1‚Äì22, 2006.[21] J. Y. Ui, S. L. Ye, J. Hana et al., ‚ÄúIdentification of antiadipogenicconstituents of the rhizomes of Anemarrhena asphodeloides,‚ÄùJournal of Natural Products, vol. 72, no. 10, pp. 1895‚Äì1898, 2009.[22] X. Ji and Y. F. Feng, ‚ÄúAdvances in studies on saponins inAnemarrhena asphodeloides,‚Äù Chinese Traditional and HerbalDrugs, vol. 41, no. 4, pp. 12‚Äì15, 2010.[23] X. Pang, L. P. Kang, H. S. Yu et al., ‚ÄúRapid isolation of newfurostanol saponins from fenugreek seeds based on ultra-performance liquid chromatography coupled with a hybridquadrupole time-of-flight tandem mass spectrometry,‚Äù Journalof Separation Science, vol. 35, no. 12, pp. 1538‚Äì1550, 2012.[24] Y. J. Kang, H. J. Chung, J. W. Nam et al., ‚ÄúCytotoxic andantineoplastic activity of timosaponin A-III for human coloncancer cells,‚Äù Journal of Natural Products, vol. 74, no. 4, pp. 701‚Äì706, 2011.[25] M. Takahashi, C. Konno, and H. Hikino, ‚ÄúIsolation and hypo-glycemic activity of anemarans A, B, C and D, glycans ofAnemarrhena asphodeloides rhizomes,‚Äù Planta Medica, vol. 2,pp. 100‚Äì102, 1985.[26] B. N. Su, Q. X. Zhu, and Z. J. Jia, ‚ÄúNor-lignan and sesquiterpenesfrom Cremanthodium ellisii,‚Äù Phytochemistry, vol. 53, no. 8, pp.1103‚Äì1108, 2000.[27] W. F. Tinto, J. L. Simmons-Boyce, S. McLean, and W. F.Reynolds, ‚ÄúConstituents of Agave americana and Agave bar-badensis,‚Äù Fitoterapia, vol. 76, no. 6, pp. 594‚Äì597, 2005.[28] W. Y. Tsui and G. D. Brown, ‚Äú(+)-Nyasol from Asparaguscochinchinensis,‚Äù Phytochemistry, vol. 43, no. 6, pp. 1413‚Äì1415,1996.[29] S. Tsukamoto, T. Wakana, K. Koimaru, T. Yoshida, M. Sato, andT. Ohta, ‚Äú7-Hydroxy-3-(4-hydroxybenzyl)chroman and Brous-sonin B: neurotrophic compounds, isolated fromAnemarrhenaasphodeloides BUNGE, function as proteasome inhibitors,‚ÄùBiological and Pharmaceutical Bulletin, vol. 28, no. 9, pp. 1798‚Äì1800, 2005.[30] J. Zhang, Z. Meng, M. Zhang, D. Ma, S. Xu, and H. Kodama,‚ÄúEffect of six steroidal saponins isolated from anemarrhenaerhizoma on platelet aggregation and hemolysis in humanblood,‚Äù Clinica Chimica Acta, vol. 289, no. 1-2, pp. 79‚Äì88, 1999.[31] Q. Sun, A. Sun, and R. Liu, ‚ÄúPreparative isolation and purifi-cation of four compounds from the Chinese medicinal herbRhizoma Anemarrhenae by high-speed counter-current chro-matography,‚Äù Journal of ChromatographyA, vol. 1104, no. 1-2, pp.69‚Äì74, 2006.[32] Z. Y. Meng, J. Y. Zhang, S. X. Xu, and K. Sugahara, ‚ÄúSteroidalsaponins from Anemarrhena asphodelaides and their effects onsuperoxide generation,‚Äù Planta Medica, vol. 65, no. 7, pp. 661‚Äì663, 1999.[33] U. J. Youn, J.-E. Jang, J.-W.Namet al., ‚ÄúAnti-respiratory syncytialvirus (RSV) activity of timosaponin A-III from the rhizomesof Anemarrhena asphodeloides,‚Äù Journal of Medicinal PlantResearch, vol. 5, no. 7, pp. 1062‚Äì1065, 2011.[34] B. Shao, H. Guo, Y. Cui, M. Ye, J. Han, and D. Guo, ‚ÄúSteroidalsaponins from smilax China and their anti-inflammatory activ-ities,‚Äù Phytochemistry, vol. 68, no. 5, pp. 623‚Äì630, 2007.Submit your manuscripts athttp://www.hindawi.comStem CellsInternationalHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014MEDIATORSINFLAMMATIONofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Behavioural NeurologyEndocrinologyInternational Journal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Disease MarkersHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014BioMed Research InternationalOncologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Oxidative Medicine and Cellular LongevityHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014PPAR ResearchThe Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Journal ofObesityJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014 Computational and  Mathematical Methods in MedicineOphthalmologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Diabetes ResearchJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Research and TreatmentAIDSHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Gastroenterology Research and PracticeHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Parkinson‚Äôs DiseaseEvidence-Based Complementary and Alternative MedicineVolume 2014Hindawi Publishing Corporationhttp://www.hindawi.com